BCPC News Alert Balchem Corp (BCPC) 66.80 12/25/2014 05:50:2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Balchem Corp (BCPC) 66.80 $BCPC

17.2% Return Seen to Date on SmarTrend Balchem Call (BCPC)
Comtex SmarTrend(R) - Wed Dec 24, 5:12PM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 months, Balchem has returned 17.15% as of today's recent price of $66.80.
BCPC: 66.80 (-1.55)

Balchem declares $0.30 dividend
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 2:06PM CST

BCPC: 66.80 (-1.55)

Balchem Corporation Announces Dividend
GlobeNewswire - Fri Dec 19, 2:00PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.30 per share, payable on January 27, 2015 to holders of record on December 29, 2014. This dividend reflects a 15% increase over the prior year cash dividend.
BCPC: 66.80 (-1.55)

Balchem Has Returned 13.7% Since SmarTrend Recommendation (BCPC)
Comtex SmarTrend(R) - Wed Dec 17, 11:15AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 months, Balchem has returned 13.68% as of today's recent price of $64.82.
BCPC: 66.80 (-1.55)

Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 36.47 (+0.43), BA: 131.24 (+1.21), BCPC: 66.80 (-1.55), MMS: 54.94 (+0.06)

United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 21.85 (-0.07), MJN: 102.04 (+0.48), CBM: 21.62 (+0.37), SIAL: 137.16 (-0.01), USNA: 103.51 (+0.91), SYUT: 5.20 (+0.07), MTEX: 28.96 (unch), BCPC: 66.80 (-1.55)

Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST

HOG: 65.56 (-0.04), LAZ: 50.95 (-0.37), AIV: 37.80 (-0.33), CNP: 23.76 (+0.31), AIT: 46.03 (+0.09), UPS: 112.41 (-0.04), SLB: 87.06 (-0.26), PRI: 54.40 (+0.05), VLO: 49.79 (+0.43), MAT: 30.22 (-0.16), AJG: 47.45 (-0.03), MMLP: 27.41 (-0.91), HME: 66.47 (-0.43), MWE: 66.40 (-0.44), RES: 13.26 (-0.35), INGR: 86.09 (-0.27), PFE: 31.42 (-0.03), ALL: 70.69 (-0.06), CLB: 122.57 (-1.35), RAS: 7.78 (-0.03), MCO: 98.29 (+0.29), FLIR: 33.34 (-0.05), SMP: 38.75 (-0.13), CPA: 101.89 (+0.50), ARCP: 8.33 (unch), HEI: 61.21 (+0.56), EWBC: 38.89 (+0.09), MKTX: 72.30 (+0.01), SNI: 78.54 (+0.85), BCPC: 66.80 (-1.55), FCF: 9.21 (-0.04), GMT: 57.30 (-0.32), ALE: 55.81 (+0.61), TAL: 43.08 (-0.18), EMCF: 25.50 (+1.00), WDR: 49.37 (-0.17), TLLP: 56.04 (+0.46), EPR: 58.50 (unch), EME: 44.55 (-0.10), PCBK: 14.28 (+0.04), X: 26.51 (+0.11), CMS: 35.69 (+0.81), LGCY: 11.86 (-0.49), CUBE: 22.59 (+0.08), AMGN: 160.67 (+3.15), EFX: 82.15 (+0.21), ATK: 113.52 (+0.59), FINL: 22.79 (+0.17), LEA: 98.23 (-0.23), TESS: 28.99 (-0.10), LB: 85.06 (unch), HPY: 55.09 (+0.34), DNB: 122.87 (-0.21), BIP: 41.48 (+0.48), TOO: 26.47 (-0.62), FIBK: 27.46 (-0.17), CNA: 38.93 (-0.06), MOFG: 28.87 (+0.04)

Balchem Announces Investment in Agglomeration Technology
GlobeNewswire - Tue Nov 25, 3:39PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its SensoryEffects business segment will make a multi-million dollar investment in agglomeration technology and production equipment to complement its market leading capabilities in drying and blending of emulsified powders for various markets.
BCPC: 66.80 (-1.55)

Post Earnings Update: Balchem Has Sunk 3.2% Lower in Past 2 Weeks (BCPC)
Comtex SmarTrend(R) - Mon Nov 24, 8:42AM CST
14 days ago, on November 10th, 2014, Balchem (NASDAQ:BCPC) reported its earnings. Analysts, on average, expected earnings of $0.51 per share on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Since the company's report, shares of Balchem have fallen from $65.73 to $63.61, representing a loss of 3.2% in the past 14 days.
BCPC: 66.80 (-1.55)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Balchem Is Down 1.4% (BCPC)
Comtex SmarTrend(R) - Mon Nov 17, 2:55PM CST
A week ago on November 10th, 2014 Balchem (NASDAQ:BCPC) reported earnings and analysts, on average, expected earnings of $0.51 on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Shares of Balchem have slipped from $65.73 to $64.84, representing a loss of 1.4%, since the company reported earnings 7 days ago.
BCPC: 66.80 (-1.55)

Uptrend Call Working As Balchem Stock Rises 14.0% (BCPC)
Comtex SmarTrend(R) - Mon Nov 17, 10:49AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 1 month, Balchem has returned 13.97% as of today's recent price of $64.99.
BCPC: 66.80 (-1.55)

Dividend Challengers (And Near-Challengers): 44 Increase Expected By January 31
David Fish - at Seeking Alpha - Mon Nov 17, 3:57AM CST

WDFC: 84.59 (-0.01), EWBC: 38.89 (+0.09), TTC: 63.54 (+0.11), OCR: 73.20 (+0.33), GE: 25.83 (-0.05), MAIN: 30.13 (+0.19), HI: 34.20 (+0.19), DEI: 28.75 (-0.13), BLX: 31.27 (+0.12), THG: 71.98 (+0.36), RL: 184.35 (+0.70), BCPC: 66.80 (-1.55), AET: 89.59 (+0.14), VTR: 71.73 (-0.89), WDR: 49.37 (-0.17), TLLP: 56.04 (+0.46), PCBK: 14.28 (+0.04), EME: 44.55 (-0.10), EPR: 58.50 (unch), CHS: 16.12 (+0.07), LGCY: 11.86 (-0.49), BMR: 21.76 (-0.15), EMN: 76.80 (+0.04), INGR: 86.09 (-0.27), PRA: 47.52 (+0.05), CUBE: 22.59 (+0.08), DIS: 94.42 (-0.27), COR: 38.83 (+0.43), BMY: 59.15 (-0.01), MORN: 66.02 (+0.08), EXL: 13.37 (+0.03), RAS: 7.78 (-0.03), CLB: 122.57 (-1.35), RCII: 36.41 (+0.40), TESS: 28.99 (-0.10), BGS: 31.25 (-0.16), TOO: 26.47 (-0.62), FIBK: 27.46 (-0.17), MAA: 76.00 (-0.21), HEI: 61.21 (+0.56), JCI: 48.50 (-0.23)

Balchem's (BCPC) CEO Dino Rossi Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 5:08PM CST

BCPC: 66.80 (-1.55)

Balchem Up 13.2% Since SmarTrend Uptrend Call (BCPC)
Comtex SmarTrend(R) - Mon Nov 10, 10:00AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 4 weeks, Balchem has returned 13.21% as of today's recent price of $64.55.
BCPC: 66.80 (-1.55)

Today's Strong And Under The Radar Stock Is Balchem (BCPC)
at The Street - Mon Nov 10, 8:47AM CST
Trade-Ideas LLC identified Balchem (BCPC) as a strong and under the radar candidate
BCPC: 66.80 (-1.55)

Blachem posts 3Q profit
Automated Insights - Mon Nov 10, 8:39AM CST
NEW HAMPTON, N.Y. (AP) _ Balchem Corp. (BCPC) on Monday reported profit of $15.2 million in its third quarter.
BCPC: 66.80 (-1.55)

Balchem beats by $0.14, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:33AM CST

BCPC: 66.80 (-1.55)

Balchem Corporation Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 8:30AM CST
Balchem Corporation (Nasdaq:BCPC) reported as follows (unaudited) for the period ended September 30, 2014.
BCPC: 66.80 (-1.55)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Beta Glucan Market Set to Exceed USD 31 Billion by 2030

Updated Category News Views 56

Exploring the Growth of the Beta Glucan Market The beta glucan market is experiencing remarkable growth, largely driven by increasing awareness of its health benefits. More and more consumers are recognizing the importance of supporting their immune systems and managing cholesterol levels, which has led to a surge in demand across numerous sectors, including...

Continue Reading
AiPPT.com: Crafting the Next Era of AI-Driven Presentations

Updated Category News Views 177

Transforming Presentations with AiPPT.com In the evolving landscape of digital work, AiPPT.com stands out as a leading provider of AI-native tools that are reshaping the way presentations are crafted. As an advanced AI presentation maker, AiPPT.com is committed to enhancing user experiences by making the process of creating engaging and professional presentations much...

Continue Reading
Acme Mills Launches Natura: Revolutionizing Sustainable Fabrics

Updated Category News Views 244

Revolutionizing Textile Innovation with Natura Acme Mills Company, a recognized pioneer in textile manufacturing, has proudly unveiled its latest innovation, Natura. This new line of bio-based polylactic acid (PLA) fabrics aims to replace traditional petroleum-based materials such as PET, PP, and Nylon. With Natura, Acme Mills is not just promoting a product; it is...

Continue Reading
Class Action Alert for C3.ai, Inc. Investors - Join Now!

Updated Category News Views 123

Opportunity for C3.ai, Inc. Shareholders to Join Class Action Attention, shareholders of C3.ai, Inc. (NYSE: AI). A significant class action suit is currently underway, and your involvement could be crucial. If you purchased shares during the class period, there may be an opportunity for you to participate in a recovery process without the requirement of being a lead...

Continue Reading
EyePoint Pharmaceuticals: Innovations and Financial Insights

Updated Category News Views 224

EyePoint Pharmaceuticals Set to Showcase Q2 Financials EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pioneering company dedicated to developing advanced therapeutics for serious retinal diseases, plans to share its second quarter 2025 financial results. This announcement will be accompanied by a live conference call and webcast on a scheduled day, promising to provide...

Continue Reading